Date | Title | Description | |
---|---|---|---|
22 Feb 2022 | On buy-back programmes | ROVI reports the end of the share buy-back programme, effective as of 3 November 2021, and the launching of a new share buy-back programme, effective as of 23 February 2022. | Download |
16 Feb 2022 | On business and financial situation | Moderna and ROVI announced that they expand their long-term collaboration for the manufacture of mRNA medicines over the next ten years | Download |
03 Nov 2021 | On buy-back programmes | The Company reports the commencement, effective as of today, 3 November 2021, of a share buyback program. | Download |
16 Jul 2021 | On Corporate Governance | ROVI announces the appointment of Juan López-Belmonte Encina as Chairman of the Company | Download |
22 Jun 2021 | On significant placements in financial instruments | Bestinver announces the beginning of an accelerated book build process of up to a 3% of the share capital of Laboratorios Rovi, S.A. | Download |
Pages
Date | Title | Description | |
---|---|---|---|
28 Jul 2021 | On business and financial situation | The company releases the press release related to first half 2021 financial results | Download |
05 Jul 2021 | Liquidity contracts and specialists | Liquidity contract: transactions conducted in the second quarter of 2021 | Download |
02 Jul 2021 | Other relevant information | The Company informs about the dividends payment | Download |
02 Jul 2021 | Other relevant information | The Company informs about the dividends payment | Download |
17 Jun 2021 | Announcement of general shareholders’ meeting | ROVI releases the information related to its General Shareholders Meeting | Download |
Pages
Date | Title | Description | |
---|---|---|---|
09 Oct 2015 | Otros sobre operaciones corporativas | Download | |
08 Oct 2015 | Otros sobre operaciones corporativas | Download | |
30 Jul 2015 | Información sobre resultados (2) | Download | |
30 Jul 2015 | Información sobre resultados | Download | |
30 Jun 2015 | Información sobre dividendos | Download |